David P. Hochman

CIK: 0001292834

Transaction Breakdown

Open Market Buys (P)14 (43.8%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)14 (43.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OBIO

Orchestra BioMed Holdings, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (32 total)

OBIO
Orchestra BioMed Holdings, Inc.
Sep 10, 2026
Tax Payment(F)
Direct
3.3K shares at avg. $5.81$19K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 10, 2026
Tax Payment(F)
Indirect
3.3K shares at avg. $5.81$19K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 3, 2026
Purchase(P)
Direct
10K shares at avg. $4.79$48K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 10, 2026
Tax Payment(F)
Direct
3.3K shares at avg. $4.02$13K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 10, 2026
Tax Payment(F)
Indirect
3.3K shares at avg. $4.02$13K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 1, 2026
Purchase(P)
Direct
5K shares at avg. $3.83$19K
OBIO
Orchestra BioMed Holdings, Inc.
May 15, 2026
Purchase(P)
Direct
5K shares at avg. $3.77$19K
OBIO
Orchestra BioMed Holdings, Inc.
Mar 25, 2026
Tax Payment(F)
Direct
32.4K shares at avg. $4.57$148K
OBIO
Orchestra BioMed Holdings, Inc.
Mar 13, 2026
Purchase(P)
Direct
10K shares at avg. $4.29$43K
OBIO
Orchestra BioMed Holdings, Inc.
Feb 12, 2026
Award(A)
Direct
504K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Dec 10, 2025
Tax Payment(F)
Direct
40.4K shares at avg. $4.67$188K
OBIO
Orchestra BioMed Holdings, Inc.
Dec 10, 2025
Tax Payment(F)
Indirect
3.3K shares at avg. $4.67$15K
OBIO
Orchestra BioMed Holdings, Inc.
Nov 14, 2025
Purchase(P)
Direct
5K shares at avg. $4.07$20K
OBIO
Orchestra BioMed Holdings, Inc.
Nov 13, 2025
Tax Payment(F)
Indirect
3.3K shares at avg. $4.18$14K
OBIO
Orchestra BioMed Holdings, Inc.
Nov 13, 2025
Tax Payment(F)
Direct
3.3K shares at avg. $4.18$14K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 17, 2025
Tax Payment(F)
Indirect
3.3K shares at avg. $2.46$8K
OBIO
Orchestra BioMed Holdings, Inc.
Sep 17, 2025
Tax Payment(F)
Direct
40.4K shares at avg. $2.46$99K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 21, 2025
Purchase(P)
Direct
6K shares at avg. $2.49$15K
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Indirect
100K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Aug 7, 2025
Award(A)
Direct
100K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Aug 4, 2025
Purchase(P)
Indirect
20K shares at avg. $2.75$55K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 11, 2025
Tax Payment(F)
Indirect
5.7K shares at avg. $3.14$18K
OBIO
Orchestra BioMed Holdings, Inc.
Jun 11, 2025
Tax Payment(F)
Direct
34K shares at avg. $3.14$107K
OBIO
Orchestra BioMed Holdings, Inc.
Apr 4, 2025
Award(A)
Direct
98.3K shares-
OBIO
Orchestra BioMed Holdings, Inc.
Mar 7, 2025
Tax Payment(F)
Direct
80.1K shares at avg. $4.23$339K

		Type	Shares	Price		Ownership
Sep 10, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$5.81	$19,074	Direct
Sep 10, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$5.81	$19,074	Indirect
Sep 3, 2026	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	10,000	$4.79	$47,900	Direct
Jun 10, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$4.02	$13,198	Direct
Jun 10, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$4.02	$13,198	Indirect
Jun 1, 2026	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	5,000	$3.83	$19,150	Direct
May 15, 2026	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	5,000	$3.77	$18,850	Direct
Mar 25, 2026	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	32,438	$4.57	$148,242	Direct
Mar 13, 2026	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	10,000	$4.29	$42,900	Direct
Feb 12, 2026	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	504,000	-	$0	Direct
Dec 10, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	40,355	$4.67	$188,458	Direct
Dec 10, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$4.67	$15,332	Indirect
Nov 14, 2025	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	5,000	$4.07	$20,350	Direct
Nov 13, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$4.18	$13,723	Indirect
Nov 13, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$4.18	$13,723	Direct
Sep 17, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	3,283	$2.46	$8,076	Indirect
Sep 17, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	40,355	$2.46	$99,273	Direct
Aug 21, 2025	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	6,000	$2.49	$14,940	Direct
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	100,000	-	-	Indirect
Aug 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	100,000	-	-	Direct
Aug 4, 2025	OBIO Orchestra BioMed Holdings, Inc.	Purchase(P)	20,000	$2.75	$55,000	Indirect
Jun 11, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	5,671	$3.14	$17,807	Indirect
Jun 11, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	34,038	$3.14	$106,879	Direct
Apr 4, 2025	OBIO Orchestra BioMed Holdings, Inc.	Award(A)	98,333	-	-	Direct
Mar 7, 2025	OBIO Orchestra BioMed Holdings, Inc.	Tax Payment(F)	80,080	$4.23	$338,738	Direct

1-25 of 32 transactions

About Hochman David P

Hochman David P (SEC CIK 0001292834) files insider reports with the SEC as Director of Orchestra BioMed Holdings, Inc. (OBIO).

Signal8 holds 21 ownership filings by Hochman David P, all Form 4s, filed between Sep 26, 2024 and Sep 11, 2026. Those filings report 32 transactions, from Sep 24, 2024 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hochman David P's filings is in NEW HOPE, PA.

Recent filings by Hochman David P

Sep 10, 2026: Tax withholdings of OBIO shares (2 lines, Form 4, code F).
Sep 3, 2026: Open-market purchase of OBIO shares (Form 4, code P).
Jun 10, 2026: Tax withholdings of OBIO shares (2 lines, Form 4, code F).
Jun 1, 2026: Open-market purchase of OBIO shares (Form 4, code P).
May 15, 2026: Open-market purchase of OBIO shares (Form 4, code P).

Other insiders filing for Orchestra BioMed Holdings, Inc. (OBIO)

Sherman Darren
Taylor Andrew Lawrence, Chief Financial Officer
Aiello Joshua, Principal Accounting Officer
Pacitti David, Director
Fain Eric S, Director
Mack John Prosper, Director

How to read Form 4 transaction codes